Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Supernus Pharmaceuticals (SUPN) PT Raised to $44 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Supernus Pharmaceuticals (SUPN)
-
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
-
TD Cowen Reiterates Buy Rating on Supernus Pharmaceuticals (SUPN)
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
-
Supernus to Present at the Cowen 43rd Annual Health Care Conference
-
Supernus to Present at the Cowen 43rd Annual Health Care Conference
-
Supernus to Participate in Annual Cowen Health Care Conference
-
Supernus to Participate in Annual Cowen Health Care Conference
-
Supernus to Present at Cowen Healthcare Conference
-
Supernus to Present at Cowen Healthcare Conference
-
Supernus Pharmaceuticals (SUPN) PT Raised to $35 at Cowen
-
Supernus to Present at the 2020 Cowen Health Care Conference
-
Supernus to Present at the 2020 Cowen Health Care Conference
-
Supernus Pharmaceuticals (SUPN) PT Lowered to $50 at Cowen
-
Supernus to Present at the 2019 Cowen Health Care Conference
-
Supernus to Present at the 2018 Cowen Health Care Conference
-
Supernus to Present at the 2018 Cowen Health Care Conference
-
Supernus Pharma (SUPN): Continued Strong Execution - Cowen
-
Supernus Pharmaceuticals (SUPN) PT Raised to $40 at Cowen
-
Supernus to Present at Cowen Health Care Conference in March
-
Streetinsider.com's Hot Lunchtime Reads 11/3: (MU) (TMH) (SUPN) (BLUE)
-
Supernus to Present at March Cowen Health Care Conference
-
UPDATE: Notable Analyst Rating Changes 6/12: (UDR) (CTXS) (DLR) Upgraded; (GMCR) (STE) (MJN) Downgraded
-
Unusual 11 Mid-Day Movers 07/18: (SUPN) (GALE) (APH) Higher; (ROVI) (WHX) (BAMM) Lower
-
Morning Movers 07/18: (SUPN) (GALE) (AIR) (APH) Higher; (ROVI) (WHX) (HHS) Lower
-
Supernus Pharmaceuticals (SUPN) IPO Traders Slightly Higher After Rocky Pricing
-
CNS Treatment Developer Supernus Pharma (SUPN) Lowers IPO Expectations

